April 17, 2020
The Food and Drug Administration announced a drug shortage for Tacrolimus, part of the in the Oral Immunosuppressives drug class. In response VDP temporarily removed the non-preferred status from the generic formulations of the NDCs below effective April 17. These changes will allow providers to prescribe for these drugs without requiring a PDL prior authorization and allow continued access to necessary medication for clients. This is a temporary change until the preferred products are sufficiently available in the market. VDP will announce any further PDL status changes of these NDCs.
Contact email@example.com for more information.
|00469060773||PROGRAF 0.5 MG CAPSULE|
|00469061773||PROGRAF 1 MG CAPSULE|
|00469065773||PROGRAF 5 MG CAPSULE|
|00469123050||PROGRAF 0.2 MG GRANULE PACKET|
|00469133050||PROGRAF 1 MG GRANULE PACKET|